Study #PA18-1077
Potential impact of the COVID-19 pandemic on financial toxicity in breast cancer surgical patients: The Impact on Out of Pocket Costs, Lost Wages and economic strain
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Breast Ductal Carcinoma in Situ;COVID-19 Infection;Hereditary Breast Carcinoma;Invasive Breast Carcinoma
Study phase:
Physician name:
Carrie Chu
Department:
Plastic Surgery
For general questions about clinical trials:
1-866-478-2259
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.